Detalhe da pesquisa
1.
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain.
Eur J Haematol
; 111(3): 485-490, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381686
2.
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients.
Ann Hematol
; 101(9): 2053-2067, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780254
3.
SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
Am J Hematol
; 97(1): 30-42, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34695229
4.
Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma.
Acta Haematol
; 145(4): 384-393, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839289
5.
Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project.
Blood Cells Mol Dis
; 68: 173-179, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836529
6.
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?
Ann Hematol
; 97(11): 2089-2098, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955943
7.
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.
Blood Cancer J
; 13(1): 8, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599843
8.
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination.
Bone Marrow Transplant
; 58(5): 567-580, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854892
9.
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders.
J Hematol Oncol
; 15(1): 54, 2022 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35526045
10.
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.
Sci Rep
; 12(1): 13057, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906470
11.
Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage.
Blood Cells Mol Dis
; 46(1): 115-8, 2011 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20934891
12.
Corrigendum to "Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update".
Adv Hematol
; 2019: 4120631, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31379947
13.
Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.
Sci Rep
; 14(1): 7400, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548834
14.
Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country.
Exp Hematol Oncol
; 9(1): 37, 2020 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33339537
15.
Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients.
Haematologica
; 88(10): 1117-22, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14555307
16.
Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.
Adv Hematol
; 2014: 986938, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25525436
17.
Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab.
Expert Rev Hematol
; 4(1): 9-16, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21322774
18.
Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
Transl Res
; 151(5): 240-5, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18433705
19.
Imatinib mesylate (STI571) treatment in patients with chronic-phase chronic myelogenous leukaemia previously submitted to autologous stem cell transplantation.
Br J Haematol
; 120(3): 500-4, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12580969